Compare Stocks: ASMB, CMPS, ANIP, and ETON

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ANIP ANI Pharmaceuticals	$74.00	$75.69	$69.58 ▼ $97.00	$1.70B	0.45	402,406 shs	229,902 shs
ASMB Assembly Biosciences	$23.67	$29.33	$21.80 ▼ $39.71	$481.92M	1.13	381,638 shs	143,522 shs
CMPS Compass Pathways	$13.06	$13.33	$4.88 ▼ $15.87	$1.81B	2.54	2.72 million shs	2.23 million shs
ETON Eton Pharmaceuticals	$57.68	$53.68	$14.27 ▼ $66.37	$1.65B	0.9	461,947 shs	502,889 shs

7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ANIP ANI Pharmaceuticals	0.00%	-2.81%	+1.61%	-12.02%	-20.47%
ASMB Assembly Biosciences	0.00%	-5.21%	-30.53%	-12.20%	-4.05%
CMPS Compass Pathways	0.00%	-14.02%	-4.88%	-13.34%	+125.17%
ETON Eton Pharmaceuticals	0.00%	+3.93%	-3.51%	+57.04%	+171.18%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ANIP ANI Pharmaceuticals	$74.00	$75.69	$69.58 ▼ $97.00	$1.70B	0.45	402,406 shs	229,902 shs
ASMB Assembly Biosciences	$23.67	$29.33	$21.80 ▼ $39.71	$481.92M	1.13	381,638 shs	143,522 shs
CMPS Compass Pathways	$13.06	$13.33	$4.88 ▼ $15.87	$1.81B	2.54	2.72 million shs	2.23 million shs
ETON Eton Pharmaceuticals	$57.68	$53.68	$14.27 ▼ $66.37	$1.65B	0.9	461,947 shs	502,889 shs

7 Stocks to Buy Before the Robotics Revolution

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ANIP ANI Pharmaceuticals	0.00%	-2.81%	+1.61%	-12.02%	-20.47%
ASMB Assembly Biosciences	0.00%	-5.21%	-30.53%	-12.20%	-4.05%
CMPS Compass Pathways	0.00%	-14.02%	-4.88%	-13.34%	+125.17%
ETON Eton Pharmaceuticals	0.00%	+3.93%	-3.51%	+57.04%	+171.18%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ANIP ANI Pharmaceuticals	2.38	Hold	$98.00	32.43% Upside
ASMB Assembly Biosciences	2.83	Moderate Buy	$47.50	100.68% Upside
CMPS Compass Pathways	2.88	Moderate Buy	$23.36	78.84% Upside
ETON Eton Pharmaceuticals	2.67	Moderate Buy	$67.50	17.02% Upside

Current Analyst Ratings Breakdown

Latest ASMB, CMPS, ANIP, and ETON Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/23/2026	ANIP ANI Pharmaceuticals	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Market Perform	$85.00
9/22/2026	ETON Eton Pharmaceuticals	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (D-) ➝ Hold (C)
9/9/2026	CMPS Compass Pathways	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
9/9/2026	ANIP ANI Pharmaceuticals	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Outperform	$104.00
9/1/2026	ASMB Assembly Biosciences	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$53.00
9/1/2026	ASMB Assembly Biosciences	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$52.00
9/1/2026	ASMB Assembly Biosciences	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$52.00
9/1/2026	ASMB Assembly Biosciences	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Outperform	$53.00 ➝ $45.00
8/24/2026	ETON Eton Pharmaceuticals	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
8/20/2026	ASMB Assembly Biosciences	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
8/18/2026	ASMB Assembly Biosciences	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$50.00

(Data available from 9/28/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ANIP ANI Pharmaceuticals	$883.37M	1.92	$9.93 per share	7.45	$24.03 per share	3.08
ASMB Assembly Biosciences	$72.30M	6.67	N/A	N/A	$13.04 per share	1.82
CMPS Compass Pathways	N/A	N/A	N/A	N/A	($0.55) per share	N/A
ETON Eton Pharmaceuticals	$79.95M	20.62	N/A	N/A	$0.98 per share	58.86

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ANIP ANI Pharmaceuticals	$78.34M	$4.64	15.95	8.60	2.36	11.07%	27.37%	10.47%	11/6/2026 (Estimated)
ASMB Assembly Biosciences	-$6.12M	$1.02	23.21	473.40	N/A	-0.06%	-0.02%	-0.02%	11/9/2026 (Estimated)
CMPS Compass Pathways	-$287.86M	-$4.62	N/A	N/A	N/A	N/A	-49.63%	-13.08%	11/3/2026 (Estimated)
ETON Eton Pharmaceuticals	-$4.60M	$0.38	151.79	29.73	N/A	12.02%	40.13%	12.37%	11/5/2026 (Estimated)

Latest ASMB, CMPS, ANIP, and ETON Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/13/2026	Q2 2026	ASMB Assembly Biosciences	-$0.7242	-$0.20	+$0.5242	-$0.20	$8.60 million	$13.37 million
8/13/2026	Q2 2026	ETON Eton Pharmaceuticals	$0.1898	$0.43	+$0.2402	$0.35	$27.11 million	$37.59 million
8/7/2026	Q2 2026	ANIP ANI Pharmaceuticals	$2.04	$2.21	+$0.17	$1.05	$260.13 million	$266.04 million
8/5/2026	Q2 2026	CMPS Compass Pathways	-$0.3881	-$1.88	-$1.4919	-$1.88	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ANIP ANI Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
ASMB Assembly Biosciences	N/A	N/A	N/A	N/A	N/A
CMPS Compass Pathways	N/A	N/A	N/A	N/A	N/A
ETON Eton Pharmaceuticals	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ANIP ANI Pharmaceuticals	0.99	2.91	2.41
ASMB Assembly Biosciences	N/A	13.99	13.99
CMPS Compass Pathways	0.60	1.30	1.30
ETON Eton Pharmaceuticals	0.41	1.52	1.30

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ANIP ANI Pharmaceuticals	76.05%
ASMB Assembly Biosciences	19.92%
CMPS Compass Pathways	46.19%
ETON Eton Pharmaceuticals	27.86%

Insider Ownership

Company	Insider Ownership
ANIP ANI Pharmaceuticals	8.10%
ASMB Assembly Biosciences	3.50%
CMPS Compass Pathways	2.82%
ETON Eton Pharmaceuticals	16.49%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ANIP ANI Pharmaceuticals	970	22.97 million	21.11 million	Optionable
ASMB Assembly Biosciences	73	20.36 million	19.65 million	Optionable
CMPS Compass Pathways	156	138.48 million	134.57 million	Optionable
ETON Eton Pharmaceuticals	44	28.58 million	23.87 million	Optionable

ASMB, CMPS, ANIP, and ETON Headlines

Recent News About These Companies

Eton Pharmaceuticals Launches IMPAVIDO in the U.S. with Expanded Patient Support and Specialty Pharmacy Access

1 hour ago | quiverquant.comQ

Eton Pharmaceuticals Announces U.S. Commercial Availability of IMPAVIDO® (miltefosine) Capsules

1 hour ago | globenewswire.com

Eton Pharmaceuticals stock gains 6.98 percent after Q2 results

September 25 at 5:17 AM | ad-hoc-news.deA

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Receives Average Recommendation of "Moderate Buy" from Analysts

September 25 at 4:28 AM | marketbeat.com

Eton Pharmaceuticals (NASDAQ:ETON) Stock Price Up 5.9% - Should You Buy?

September 24, 2026 | marketbeat.com

Eton Pharmaceuticals stock reports 99 percent Q2 revenue growth

September 23, 2026 | ad-hoc-news.deA

Eton Pharmaceuticals stock edges higher after strong 2025 growth figures

September 20, 2026 | ad-hoc-news.deA

Eton Pharmaceuticals stock holds steady as insider sales and recent results shape the picture

September 18, 2026 | ad-hoc-news.deA

Squarepoint Ops LLC Invests $2.16 Million in Eton Pharmaceuticals, Inc. $ETON

September 15, 2026 | marketbeat.com

HighTower Advisors LLC Acquires 34,484 Shares of Eton Pharmaceuticals, Inc. $ETON

September 14, 2026 | marketbeat.com

Hsbc Holdings PLC Makes New $1.53 Million Investment in Eton Pharmaceuticals, Inc. $ETON

September 13, 2026 | marketbeat.com

118,249 Shares in Eton Pharmaceuticals, Inc. $ETON Purchased by Bank of New York Mellon Corp

September 6, 2026 | marketbeat.com

ETON stock holds firm after latest quarter shows steady growth

September 5, 2026 | ad-hoc-news.deA

Sigma Planning Corp Takes Position in Eton Pharmaceuticals, Inc. $ETON

September 2, 2026 | marketbeat.com

Hsbc Holdings PLC Invests $1.53 Million in Eton Pharmaceuticals, Inc. $ETON

September 1, 2026 | marketbeat.com

34,027 Shares in Eton Pharmaceuticals, Inc. $ETON Acquired by Jefferies Financial Group Inc.

August 31, 2026 | marketbeat.com

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Given Consensus Recommendation of "Moderate Buy" by Analysts

August 31, 2026 | marketbeat.com

Deutsche Bank AG Purchases Shares of 26,522 Eton Pharmaceuticals, Inc. $ETON

August 31, 2026 | marketbeat.com

BlackRock Inc. Invests $68.63 Million in Eton Pharmaceuticals, Inc. $ETON

August 31, 2026 | marketbeat.com

Un initié d'Eton Pharmaceuticals a vendu des actions pour une valeur de 2 953 572 $, selon un récent dépôt auprès de la SEC

August 30, 2026 | zonebourse.comZ

Navellier & Associates Inc. Makes New Investment in Eton Pharmaceuticals, Inc. $ETON

August 30, 2026 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

ASMB, CMPS, ANIP, and ETON Company Descriptions

ANI Pharmaceuticals NASDAQ:ANIP

$74.00 0.00 (0.00%)

Closing price 09/25/2026 04:00 PM Eastern

Extended Trading

$74.00 +0.00 (+0.01%)

As of 09/25/2026 07:30 PM Eastern

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Assembly Biosciences NASDAQ:ASMB

$23.67 0.00 (0.00%)

Closing price 09/25/2026 04:00 PM Eastern

Extended Trading

$23.72 +0.04 (+0.19%)

As of 09/25/2026 07:30 PM Eastern

Assembly Biosciences, Inc., a biotechnology company, develops therapeutic candidates for the treatment of viral diseases. It develops ABI-5366, a long-acting herpes simplex virus (HSV) helicase-primase inhibitor that is in Phase 1a/1b clinical trial to treat recurrent genital herpes; ABI-1179, which is in Phase 1a/1b clinical trial for the treatment of recurrent genital herpes; and ABI-6250, a small molecule orally bioavailable hepatitis delta virus entry inhibitor that is in Phase 1a clinical trial. The company also develops ABI-4334, a next-generation capsid assembly modulator, which is in Phase 1b clinical trial for the treatment of hepatitis B virus (HBV). In addition, it develops an oral non-nucleoside polymerase inhibitor targeting transplant-related herpesviruses; and a small molecule interferon-a receptor agonist targeting HBV and HDV. The company has collaboration agreements with Gilead Sciences, Inc. and BeiGene, Ltd. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was incorporated in 2005 and is headquartered in South San Francisco, California.

Compass Pathways NASDAQ:CMPS

$13.06 0.00 (0.00%)

Closing price 09/25/2026 04:00 PM Eastern

Extended Trading

$13.12 +0.06 (+0.50%)

As of 09/25/2026 07:57 PM Eastern

Compass Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to Compass Pathways plc in August 2020. Compass Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.

Eton Pharmaceuticals NASDAQ:ETON

$57.68 0.00 (0.00%)

Closing price 09/25/2026 04:00 PM Eastern

Extended Trading

$58.51 +0.83 (+1.44%)

As of 09/25/2026 07:30 PM Eastern

Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing, acquiring, and commercializing pharmaceutical products for rare diseases. The company offers ALKINDI SPRINKLE, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of tyrosinemia type 1. It also provides Zeneo hydrocortisone autoinjector for the treatment of adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ASMB, CMPS, ANIP, and ETON Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ASMB, CMPS, ANIP, and ETON Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ASMB, CMPS, ANIP, and ETON Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

ASMB, CMPS, ANIP, and ETON Company Descriptions

ANI Pharmaceuticals NASDAQ:ANIP

Assembly Biosciences NASDAQ:ASMB

Compass Pathways NASDAQ:CMPS

Eton Pharmaceuticals NASDAQ:ETON

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ASMB, CMPS, ANIP, and ETON Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ASMB, CMPS, ANIP, and ETON Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ASMB, CMPS, ANIP, and ETON Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

ASMB, CMPS, ANIP, and ETON Company Descriptions

ANI Pharmaceuticals NASDAQ:ANIP

Assembly Biosciences NASDAQ:ASMB

Compass Pathways NASDAQ:CMPS

Eton Pharmaceuticals NASDAQ:ETON

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools